Pfizer Korea to sue Kukje Pharm for amlodipine patent infringement

Pfizer Korea will likely to file a lawsuit against Kukje Pharm's amlodipine besylate generic for infringement of its Norvasc patent. Pfizer Korea will seek a court injunction for kukje's Norvasc generic drug, according to the industry sources. Pfizer's proprietorship of amlodipine besylate technologies is widely recognized throughout the industry and the unlicensed use of our intellectual...